Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Regular exercise that follows established guidelines for physical activity in MS lead to clinically meaningful improvements ...

A six-week music-based intervention may reduce psychosocial fatigue and heat pain sensitivity in people with multiple ...

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

Researchers have developed a blood test to predict MS onset by measuring EBV antibody levels, potentially allowing early diagnosis and care.

A person's total number of visits to multiple sclerosis clinics is not associated with a lower risk of death, a study on ...

To clarify aspects of multiple sclerosis that might be confusing, columnist Ben Hofmeister tries to use humor, analogies, and metaphors.